ReutersReuters

Structure Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

RefinitivBacaan kurang dari 1 minit
  • Structure Therapeutics Inc GPCR is expected to show no change in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Structure Therapeutics Inc is for a loss of 28 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Structure Therapeutics Inc is $75.00, about 77.6% above its last closing price of $16.78

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-0.22

-0.23

-0.81

Missed

-253.9

Dec. 31 2025

-0.23

-0.22

-0.69

Missed

-208.3

Sep. 30 2024

-0.17

-0.19

-0.60

Missed

-222.8​

Jun. 30 2024

-0.22

-0.23

-0.54

Missed

-137.9

​​Mar. 31 2024

-0.21

-0.21

-0.57

Missed

-170.5

Dec. 31 2023

-0.21

-0.21

-0.66

Missed

-217.3​

Sep. 30 2023

-0.37

-0.29

-0.62

Missed

-112.9

Jun. 30 2023

-0.20

-0.28

-0.60

Missed

-116.3

This summary was machine generated August 4 at 21:58 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini